Home Cart Sign in  
Chemical Structure| 40592-88-9 Chemical Structure| 40592-88-9

Structure of TLR4-IN-C34
CAS No.: 40592-88-9

Chemical Structure| 40592-88-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TLR4-IN-C34, a TLR4 inhibitor, improves systemic inflammation IN endotoxemia and necrotizing enterocolitis models.

Synonyms: TLR4-C34; C34; Toll-Like Receptor 4-C34

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TLR4-IN-C34

CAS No. :40592-88-9
Formula : C17H27NO9
M.W : 389.40
SMILES Code : CC(OC[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](NC(C)=O)[C@@H](OC(C)C)O1)=O
Synonyms :
TLR4-C34; C34; Toll-Like Receptor 4-C34
MDL No. :MFCD28053519
InChI Key :KMIQMFHPUJUDMC-HHARLNAUSA-N
Pubchem ID :91691128

Safety of TLR4-IN-C34

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of TLR4-IN-C34

pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Neonatal hypoxic-ischemic brain damage (HIBD) model Oral 1 mg/kg Once daily from the 7th postnatal day to the 3rd day after HI insult TLR4-IN-C34 improved cognitive impairment and neuroinflammation in neonatal HIBD rats by inhibiting the intestinal LPS/TLR4 signaling pathway. PMC11866968
Sprague-Dawley rats Neonatal hypoxic-ischemic brain damage (HIBD) model Oral 1 mg/kg Once daily from the 7th postnatal day to the 3rd day after HI insult TLR4-IN-C34 improved intestinal dysfunction, reduced systemic inflammation, and alleviated synaptic damage and cognitive impairments in neonatal HIBD rats by inhibiting the intestinal LPS/TLR4 signaling pathway. PMC11866968

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.57mL

0.51mL

0.26mL

12.84mL

2.57mL

1.28mL

25.68mL

5.14mL

2.57mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories